| |
| |
| Foreword | |
| |
| |
| Preface | |
| |
| |
| Abbreviations | |
| |
| |
| |
| Inventing Neurosomatic Medicine: Rewards and Satisfactions Versus Problems and Pitfalls | |
| |
| |
| |
| The Education of a Neurosomaticist | |
| |
| |
| |
| The Office Practice of Neurosomatic Medicine | |
| |
| |
| Bankruptcy Despite a Three-Month Waiting List | |
| |
| |
| Solving the Problems and Avoiding the Pitfalls | |
| |
| |
| Taking Care of Business | |
| |
| |
| |
| Lawyers and Litigation | |
| |
| |
| Sample Pathophysiology of Posttraumatic Fibromyalgia | |
| |
| |
| Mene, Mene, Tekel, Upharsin | |
| |
| |
| |
| Treatment Case Examples | |
| |
| |
| Instantaneous Neural Network Reconfiguration by Pharmacologic Modulation of Afferent Cranial Nerve Input | |
| |
| |
| The Pathophysiology of CFS and Related Neurosomatic Disorders | |
| |
| |
| Thyroid Function in Neurosomatic Disorders: Stimulation of Trigeminal Nerve Activity with Thyrotropin-Releasing Hormone (TRH) | |
| |
| |
| |
| Case Reports | |
| |
| |
| My So-Called Illness: Is It Real or All in My Head? | |
| |
| |
| One-Second Epiphanies | |
| |
| |
| My Most Unusual Case | |
| |
| |
| Bug-of-the-Month Club | |
| |
| |
| |
| Married to a Doctor Who Is Married to His Practice | |
| |
| |
| |
| Society for Neuroscience Conference Proceedings | |
| |
| |
| |
| This Is ... Los Angeles | |
| |
| |
| |
| Neurosomatic Pearls | |
| |
| |
| Eldritch Lore About Neurosomatic Therapy | |
| |
| |
| |
| Neurosomatic Neuroscience | |
| |
| |
| |
| Pathophysiology and Treatment | |
| |
| |
| |
| Treatment of Neurosomatic Disorders | |
| |
| |
| Abecarnil and Acamprosate | |
| |
| |
| Stimulants | |
| |
| |
| The Corticostriatal-Thalamocortical (CSTC) Circuit in Reverse | |
| |
| |
| Corticotropin-Releasing Hormone (CRH) and Hypocortisolism | |
| |
| |
| Agmatine | |
| |
| |
| Cholinesterase Inhibitors | |
| |
| |
| Ascorbate (Vitamin C) | |
| |
| |
| Amantadine | |
| |
| |
| Adenosine | |
| |
| |
| Baclofen | |
| |
| |
| Gamma-Aminobutyric Acid (GABA) | |
| |
| |
| Adenosine Triphosphate (ATP) | |
| |
| |
| Lorazepam Nasal Spray | |
| |
| |
| Antibiotics | |
| |
| |
| Endothelin (ET) | |
| |
| |
| Respiratory Rhythm Regulation in Fibromyalgia Syndrome | |
| |
| |
| pH and Panic Disorder | |
| |
| |
| Buspirone/BuSpar | |
| |
| |
| Thalamic Reticular Nucleus | |
| |
| |
| The Attentional Network | |
| |
| |
| Clonidine | |
| |
| |
| Catecholamines | |
| |
| |
| Norepinephrine, Dopamine, Salience, and Attention | |
| |
| |
| Dopamine and Reward | |
| |
| |
| Effexor (Venlafaxine) | |
| |
| |
| Synaptic Plasticity and Long-Term Potentiation in Neurosomatic Disorders | |
| |
| |
| The Postreceptor Phosphorylation Cascade | |
| |
| |
| The Treatment of Attentional Disorders | |
| |
| |
| Instantaneous Neural Network Reconfiguration | |
| |
| |
| Other Aspects of Synaptic Plasticity | |
| |
| |
| Hormonal Modulation in Neurosomatic Medicine | |
| |
| |
| Modulating the N-Methyl-D-Aspartate (NMDA) Receptor | |
| |
| |
| Atypical Messengers | |
| |
| |
| Synaptic Fatigue | |
| |
| |
| Glutamate Receptors, Subunits, and Synaptic Scaling | |
| |
| |
| Neurotrophic Factors | |
| |
| |
| Metabotropic Glutamate Receptors | |
| |
| |
| Conclusion | |
| |
| |
| |
| Modulating Glutamatergic Neurotransmission | |
| |
| |
| Ketamine | |
| |
| |
| Pharmacologic Modulation of Sensory Integration via the Trigeminal Nerve | |
| |
| |
| Electroconvulsive Therapy (ECT) | |
| |
| |
| Kinases and Phosphatases | |
| |
| |
| The Nicotinic Cholinergic Receptor | |
| |
| |
| Long-Term Potentiation and Depression | |
| |
| |
| Mitogen-Activated Protein Kinases (MAPKs) | |
| |
| |
| Gabapentin | |
| |
| |
| Zolpidem | |
| |
| |
| Lamotrigine | |
| |
| |
| Pentazocine (Talwin) | |
| |
| |
| Oxytocin | |
| |
| |
| Opioids | |
| |
| |
| Oxytocin, Hypothalamic Function, and Circadian Rhythms | |
| |
| |
| Other Effects of Oxytocin | |
| |
| |
| Modafinil (Provigil) | |
| |
| |
| Ventrolateral Preoptic Nucleus (VLPO) | |
| |
| |
| Lidocaine | |
| |
| |
| Gonadotropin-Releasing Hormone (GnRH) and Dysregulation of Circadian Rhythms | |
| |
| |
| Pyrrolidines | |
| |
| |
| Fatigue | |
| |
| |
| Sleep | |
| |
| |
| Conclusion | |
| |
| |
| Conclusion: Closing the Circuit: The Role of the Nucleus Accumbens in Neurosomatic Disorders | |
| |
| |
| Appendix | |
| |
| |
| Diagnostic Criteria from the DSM-IV-TR | |
| |
| |
| Treatment Algorithm | |
| |
| |
| Medication List: Present and Near-Future Treatment Options for Neurosomatic Disorders | |
| |
| |
| CFS Symptom Checklist | |
| |
| |
| References | |
| |
| |
| Index | |